<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Accuracy, reliability, feasibility and nurse acceptance of a subcutaneous continuous glucose management system in critically ill patients: a prospective clinical trial</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Tobias</forename><surname>Wollersheim</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Jo</forename><surname>Lilian</surname></persName>
						</author>
						<author>
							<persName><surname>Engelhardt</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Jeanne</forename><surname>Pachulla</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Rudolf</forename><surname>Moergeli</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Susanne</forename><surname>Koch</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Claudia</forename><surname>Spies</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Michael</forename><surname>Hiesmayr</surname></persName>
						</author>
						<author role="corresp">
							<persName><forename type="first">Steffen</forename><surname>Weber-Carstens</surname></persName>
							<email>steffen.weber-carstens@charite.de</email>
							<idno type="ORCID">0000-0001-7405-0172</idno>
						</author>
						<author>
							<persName><forename type="first">Lilian</forename><surname>Jo</surname></persName>
						</author>
						<author>
							<affiliation>
								<orgName>1 Department of Anesthesiology and Operative Intensive Care Medicine, Campus Charité Mitte and Campus Virchow Klinikum, Charité -Universitätsmedizin Berlin, </orgName>
								<address><addrLine>Augustenburger Platz 1, 13353 Berlin, Germany Augustenburger Platz 1, 13353 Berlin, Germany. Berlin, Germany. Vienna, Austria.</addrLine></address>
							</affiliation>
						</author>
						<author>
							<affiliation>
								<orgName> 1 Department of Anesthesiology and Operative Intensive Care Medicine, Campus Charité Mitte and Campus Virchow Klinikum, Charité -Universitätsmedizin Berlin, </orgName>
							</affiliation>
						</author>
						<author>
							<affiliation>
								<orgName> 2 Berlin Institute of Health (BIH), </orgName>
							</affiliation>
						</author>
						<author>
							<affiliation>
								<orgName> 3 Division Cardiac-, Thoracic-, Vascular Anesthesia and Intensive Care, Medical University Vienna,</orgName>
							</affiliation>
						</author>
						<title level="a" type="main">Accuracy, reliability, feasibility and nurse acceptance of a subcutaneous continuous glucose management system in critically ill patients: a prospective clinical trial</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">651DA725FB8068E64F7E122C01573855</idno>
					<idno type="DOI">10.1186/s13613-016-0167-z</idno>
					<note type="submission">Received: 24 February 2016 Accepted: 28 June 2016</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:33+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Trial registration NCT02296372; Ethic vote Charité EA2/095/14 Continuous glucose monitoring</term>
					<term>Subcutaneous</term>
					<term>Interstitial</term>
					<term>Critically ill patients</term>
					<term>ICU</term>
					<term>Medtronic Sentrino ®</term>
					<term>Accuracy</term>
					<term>Reliability</term>
					<term>Feasibility</term>
					<term>Nurse acceptance</term>
					<term>Evaluation</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Background: Continuous glucose monitoring (CGM)  has not yet been implemented in the intensive care unit (ICU) setting.</s><s>The purpose of this study was to evaluate reliability, feasibility, nurse acceptance and accuracy of the Medtronic Sentrino ® CGM system in critically ill patients.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods:</head><p><s>Sensors were inserted into the subcutaneous tissue of the patient's thigh, quantifying interstitial glucose concentration for up to 72 h per sensor.</s><s>Reliability and feasibility analysis included frequency of data display, data gaps and reasons for sensor removal.</s><s>We surveyed nurse acceptance in a questionnaire.</s><s>For the accuracy analysis, we compared sensor values to glucose values obtained via blood gas analysis.</s><s>Potential benefits of CGM were investigated in intra-individual analyses of factors, such as glycemic variability or time in target range achieved with CGM compared to that achieved with intermittent glucose monitoring.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results:</head><p><s>The device generated 68,655 real-time values from 31 sensors in 20 critically ill patients.</s><s>532 comparative blood glucose values were collected.</s><s>Data were displayed during 32.5 h [16.0/62.4]</s><s>per sensor, which is 45.1 % of the expected time of 72 h and 84.8 % of 37.9 h actual monitoring time.</s><s>21 out of 31 sensors were removed prematurely.</s><s>79.1 % of the nursing staff rated the device as not beneficial; the response rate was one-third.</s><s>Mean absolute relative difference was 15.3 % (CI 13.5-17.0</s><s>%).</s><s>Clarke error grid: 76.9 % zone A, 21.6 % zone B, 0.2 % zone C, 0.9 % zone D, 0.4 % zone E. Bland-Altman plot: mean bias +0.53 mg/dl, limits of agreement +64.6 and −63.5 mg/dl.</s><s>Accuracy deteriorated during elevated glycemic variability and in the hyperglycemic range.</s><s>There was no reduction in dysglycemic events during CGM compared to 72 h before and after CGM.</s><s>If CGM was measuring accurately, it identified more hyperglycemic events when compared to intermittent measurements.</s><s>This study was not designed to evaluate potential benefits of CGM on glucose control.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusions:</head><p><s>The subcutaneous CGM system did not perform with satisfactory accuracy, feasibility, or nursing acceptance when evaluated in 20 medical-surgical ICU patients.</s><s>Low point accuracy and prolonged data gaps</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Background</head><p><s>Critically ill patients frequently experience stress-induced alterations in glucose homoeostasis resulting in hyperglycemia <ref type="bibr" target="#b0">[1]</ref>.</s><s>Peripheral insulin resistance and an enhanced hepatic glucose production, caused by a release of counterregulatory hormones and cytokines, are contributing mechanisms <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b1">2]</ref>.</s><s>Insufficient GLUT4 translocation in skeletal muscle of critically ill patients is related to glucose dysregulation <ref type="bibr" target="#b2">[3]</ref>.</s><s>Hyperglycemia, elevated glycemic variability and hypoglycemia, were associated with an increased mortality risk in critically ill patients <ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref>.</s><s>Randomized controlled trials showed that insulin therapy and management of glycemic control in the ICU remains challenging <ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref><ref type="bibr" target="#b7">[8]</ref><ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref>.</s></p><p><s>Continuous glucose monitoring (CGM) in the ICU, combined with an appropriate insulin protocol, may improve management of glycemic control and consequently impact patient outcome <ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref><ref type="bibr" target="#b12">[13]</ref>.</s><s>Wernerman et al. provided an overview of CGM technologies, including glucose oxidase, mid-infrared spectroscopy and fluorescence, ranging from invasive intravascular devices to minimally invasive interstitial and noninvasive transcutaneous systems <ref type="bibr" target="#b10">[11]</ref>.</s><s>Interstitial devices designed for use in diabetic patients have already been applied in critically ill patients <ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref>.</s><s>Despite promising attempts, these systems have not yet been implemented to daily routine in the ICU and improvements are desirable.</s><s>The subcutaneous Medtronic Sentrino ® CGM system was designed for use in ICU patients.</s><s>The displayed real-time glucose trend line allows the ICU staff to observe glucose excursions at an earlier stage when compared to the established intermittent measurements.</s><s>Patients may benefit from increased time in target range and improved glycemic variability.</s><s>In addition, nurse workload may be reduced.</s></p><p><s>The purpose of this study was to evaluate reliability, feasibility, nurse acceptance and accuracy of this subcutaneous CGM system, as well as to identify potential weaknesses of the device in severely ill patients.</s><s>In addition to previous studies <ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b18">[19]</ref>, we retrospectively assessed potential benefits of CGM in comparison with intermittent glucose monitoring in our medical-surgical ICU.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Inclusion criteria and study participants</head><p><s>Inclusion criteria included an expected length of stay in the ICU of at least 72 h, age ≥18 years and written informed consent given by patient or legal proxy.</s><s>We recruited critically ill patients during a time period of seven months in 2014.</s><s>Patient inclusion started immediately after the local ethics committee, Ethikkommission Charité Universitätsmedizin Berlin, approved the study protocol (Charité-EA2/095/14).</s><s>The protocol was registered under https://clinicaltrials.gov, trial registration number NCT02296372.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Glycemic control in the study setting</head><p><s>The single-center study was set in two interdisciplinary mixed medical-surgical ICUs of a university hospital.</s><s>The glucose target levels for insulin therapy were 80-149 mg/ dl.</s><s>Dysglycemic events were defined as follows: ranges above 149 mg/dl represented moderate hyperglycemia, and glucose levels above 179 mg/dl represented severe hyperglycemia.</s><s>Moderate hypoglycemia was defined in a range from 41 to 70 mg/dl, and severe hypoglycemia as ≤40 mg/dl <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b19">20]</ref>.</s><s>Due to general ICU routine, nurses took blood samples from an arterial catheter in 2-to 4-h intervals, depending on the patient's condition.</s><s>In the absence of an arterial line, blood was collected from a central or peripheral venous catheter.</s><s>Blood glucose was determined by glucose oxidase reaction using a Radiometer ABL 800 FLEX (Copenhagen, Denmark) blood gas analyzer.</s><s>Depending on the identified blood glucose value, the nursing staff regulated the intravenous insulin therapy according to the local insulin protocol (Additional file 1: Table <ref type="table" target="#tab_0">S1</ref>).</s><s>All patient data, including blood gas analyses, were documented within the patient data management system (PDMS).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CGM sensor</head><p><s>According to manufacturer's information, the sensors of the interstitial CGM device consist of four independently working electrodes, which are embedded in two cannulas.</s><s>This multisensory system provides enhanced signal stability and accuracy in critically ill patients.</s><s>The electrodes are coated by glucose oxidase.</s><s>In the enzymatic reaction, electrons are released and create an electrical gradient, which is proportional to the interstitial glucose concentration.</s><s>Based on the electrical signal, the CGM algorithm calculates out of the four data signals one blood glucose value, which is displayed on a bedsided monitor.</s><s>The device provides one real-time glucose measurement per minute, with an insignificant lag time for signal processing, for up to 72 h (for more details, see Additional file 1: CGM Device).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study procedure</head><p><s>We inserted the sensors into the subcutaneous tissue of patient's upper leg.</s><s>After initialization, the sensors required one initial blood glucose entry, followed by two further calibrations after the first and second running hour.</s><s>Subsequently, the study team performed calibrations every 8 h, as proposed by the manufacturer.</s><s>The ward staff were not required to perform further calibrations.</s><s>We instructed nurses to observe the continuous glucose trend line and perform blood glucose measurements to adapt insulin therapy in case of excursions above or below the target range (defined in the local insulin protocol Additional file 1: Table <ref type="table" target="#tab_0">S1</ref>).</s><s>Glucose values determined by the blood gas analyzer were used as reference.</s><s>Blood glucose measurements used for initial calibrations and calibrations after data gaps (&gt;15 min) were excluded from the point accuracy analysis.</s><s>Further blood glucose measurements were included and compared to the latest CGM value immediately before calibration.</s><s>As specified in the study protocol (Fig. <ref type="figure">1</ref>), the accuracy analysis required a minimum monitoring time of 48 h or at least 12 comparative readings.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Analysis criteria</head><p><s>Figure <ref type="figure" target="#fig_0">2</ref> illustrates detailed endpoints for the analysis of reliability, feasibility, nurse acceptance, accuracy and potential benefits of CGM.</s><s>The analysis is based on the 2013 consensus recommendations, published by Finfer et al. defining criteria for continuous glucose control in critically ill patients <ref type="bibr" target="#b19">[20]</ref>.</s><s>Desirable reliability criteria include a continuous data display during &gt;95 % of time and device-related data gaps &lt;30 min <ref type="bibr" target="#b19">[20]</ref>.</s><s>We calculated frequency of data gaps and analyzed the gaps subdivided as very brief (&lt;15 min), brief (15-30 min), prolonged (&gt;30 min) and very prolonged (&gt;2 h), so as to better describe the clinical significance of the missing trend data.</s><s>The feasibility analysis considered the capacity of the device to perform within the busy ICU setting.</s><s>This was supplemented by a survey of nurse acceptance assessed by brief questionnaires given to the nurses in charge of each shift (Additional file 1: Fig. <ref type="figure">S3</ref>).</s><s>To determine accuracy, sensor values were compared to the simultaneously recorded blood glucose values from PDMS.</s><s>We calculated point accuracy according to criteria specified within the consensus recommendations <ref type="bibr" target="#b19">[20]</ref>, which can be summarized as follows</s></p><p><s>• 98 % of device readings should be within 12.5 % of a reference standard (or within ±10 mg/dl for readings &lt;100 mg/dl) • The remaining 2 % of readings should be within 20 % of a reference standard • Mean absolute relative difference (MARD) should be &lt;14 % (M)ARD = │(blood glucose − sensor glucose)│/blood glucose × 100 • MARD &gt; 18 % represents poor accuracy.</s></p><p><s>In addition, we analyzed possible confounding factors on MARD, such as arterial pO 2 , temperature, hemoglobin, potassium, lactate, pH value, sequential organ failure assessment (SOFA) Score, systemic inflammatory response syndrome (SIRS), history of diabetes, blood glucose variability and glucose ranges (&lt;80 mg/ dl, 80-179 mg/dl, &gt;179 mg/dl).</s><s>We retrospectively calculated MARD after time-shifting the reference a fixed amount (1 up to 30 min), so as to investigate a time delay as a possible confounding factor.</s><s>To investigate potential benefits of CGM in our ICU, we report glycemic control achieved with CGM compared to that achieved with intermittent glucose monitoring.</s><s>This was accomplished by performing intra-individual analyses, longitudinal and parallel, of factors such as mean blood glucose level, blood glucose variability, number of dysglycemia events and time in blood glucose target range (Fig. <ref type="figure" target="#fig_0">2</ref>).</s><s>Glycemic variability was determined using standard deviation of blood glucose and glycemic lability index (Table <ref type="table">4b</ref>), as a Fig. <ref type="figure">1</ref> Study procedure.</s><s>We included n = 20 patients during 57 days of recruiting.</s><s>One patient was excluded from the accuracy analysis due to a lack of comparative blood glucose samples.</s><s>Ten patients required a second sensor to achieve the minimum number of comparative samples or a minimum running time of 48 h.</s><s>We used an optional second sensor in one patient time-weighted index <ref type="bibr" target="#b20">[21]</ref>.</s><s>To evaluate safety, we reported local complications and discussed patient risks due to inaccurate CGM measurements in a safety statement.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analysis</head><p><s>Results were shown as median with interquartile range or as absolute numbers with percentages.</s><s>Clinical accuracy was illustrated using Bland-Altman plot <ref type="bibr" target="#b21">[22]</ref>, Clarke error grid <ref type="bibr" target="#b22">[23]</ref> and Surveillance Error-Grid <ref type="bibr" target="#b23">[24]</ref>.</s><s>We calculated glycemic lability index using EasyGV© software <ref type="bibr" target="#b20">[21]</ref>.</s><s>Nonparametric tests were performed (Mann-Whitney U Test, Wilcoxon Test, Kruskal-Wallis Test, Friedman Test and Spearman's correlation).</s><s>We used IBM© SPSS© Statistics version 21, Microsoft Excel© 2010 and R for the statistical analysis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p><s>We included 20 critically ill patients in this prospective trial using a total of 31 sensors (Fig. <ref type="figure">1</ref>).</s><s>Table <ref type="table" target="#tab_0">1</ref> shows patient characteristics.</s><s>In total, the device generated 68655 (1144.3</s><s>h) real-time glucose values during 1337.1 h of monitoring.</s><s>The median monitoring time per patient was 70.5 h [57.2/72.7].</s><s>For the accuracy comparison, we collected 532 blood glucose values in 19 patients, of which 475 (89.3 %) were obtained from arterial and 57 (10.7 %) from venous catheters.</s><s>There was no significant difference in accuracy between the 475 arterial blood glucose values compared to all 532 glucose values (p = .799).</s><s>Table <ref type="table" target="#tab_1">2</ref> shows a summary of glycemic control metrics.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Reliability, feasibility and safety</head><p><s>The reliability analysis showed a real-time data display during 32.5 h (16/62.4)</s><s>per sensor, which is 45.1 % of the expected time of 72 h and 84.8 % of the 37.9 h actual monitoring time.</s><s>During 80223 min (1337.1 h) of monitoring, we observed in total 11568 min (192.8</s><s>h) of missing values.</s><s>The number of data gaps was 155, of which 68 (43.9 %) were very brief (&lt;15 min), 35 (22.6 %) were brief (15-30 min), 27 (17.4</s><s>%) were prolonged (30-120 min) and 25 (16.1 %) were very prolonged.</s><s>The sensor insertion itself was easily performed and required less than 10 min.</s><s>The complication rate at the site was low.</s><s>Minor bleeding after insertion occurred in four patients.</s><s>We observed no local infection.</s><s>The main feasibility issue was premature sensor removal.</s><s>Detailed device reliability and feasibility is shown in Table <ref type="table" target="#tab_2">3</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Nurse acceptance</head><p><s>The nurses received 128 questionnaires during the CGM monitoring period.</s><s>The response rate was one-third (n = 43, 34 %).</s><s>The majority (79.1 %) of the nursing staff rated the device as not beneficial in the daily ICU routine.</s><s>Advantages, such as the opportunity to observe glucose trends, were reported in 20.9 % of the questionnaires.</s><s>Disadvantages were described by 53.5 %.</s><s>Reasons included the inadequate alarm performance (23.3 %), the additional device (23.3 %) and device line (6.9 %) as disturbing factors during bedding and mobilization in the ICU routine.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Point accuracy</head><p><s>60.3 % of sensor data were within 12.5 % from the reference blood glucose (or were within ±10 mg/dl for readings &lt;100 mg/dl).</s><s>In total, 76.9 % of sensor readings were within 20, and 23.1 % deviated more than 20 % from the reference.</s><s>MARD was 15.3 % (95 % CI 13.5-17.0</s><s>%).</s><s>Spearman's correlation coefficient was 0.688, p &lt; .001,</s><s>r 2 = 0.461.</s><s>The Bland-Altman plot (Fig. <ref type="figure">3a</ref>) showed a mean bias of 0.53 mg/dl and limits of agreement of +64.6 mg/dl and −63.5 mg/dl.</s><s>Clarke error grid and Color-Coded Surveillance Error-Grid (Fig. <ref type="figure">3b, c</ref>) showed potentially dangerous errors.</s><s>Additional file 1: Table <ref type="table" target="#tab_1">S2</ref> shows the detection of dysglycemic events.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Confounding factors on accuracy</head><p><s>We identified that the blood glucose variability, analyzed in standard deviation, was significantly associated with CGM accuracy (Fig. <ref type="figure">4a</ref>).</s><s>Confirming this finding, standard deviation per patient was positively correlated with MARD per patient k = 0.593, p = .001,</s><s>n = 19, r 2 = 0.298 (Additional file 1: Fig. <ref type="figure">S1</ref>).</s><s>MARD deteriorated in the hyperglycemic blood glucose range (Fig. <ref type="figure">4a</ref>).</s><s>There was no significant improvement or deterioration of MARD after time-shifting the reference glucose a fixed amount of 1 up to 30 min (Additional file 1: Fig. <ref type="figure" target="#fig_0">S2</ref>).</s><s>MARD was worse during application of vasoconstrictors (Additional file 1: Table <ref type="table" target="#tab_2">S3a</ref>).</s><s>Previously known diabetes mellitus and episodes of SIRS did not confound MARD (Additional file 1: Table <ref type="table" target="#tab_2">S3a</ref>).</s><s>The severity of disease, measured via SOFA Score, showed a minor positive correlation with the MARD (k = 0.088, p = .043,</s><s>r 2 = 0.006, n = 532).</s></p><p><s>There was no significant correlation of arterial pO2, temperature, pH value, lactate, hemoglobin, or potassium and MARD (Additional file 1: Table <ref type="table" target="#tab_2">S3b</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Potential benefits of CGM in our ICU</head><p><s>In 10 patients with an ICU stay of at least nine consecutive days, the longitudinal analysis showed no significant reduction in dysglycemic events during 3 days of CGM compared to 72 h before and 72 h after CGM (Table <ref type="table">4a</ref>).</s></p><p><s>In the parallel analysis, CGM determined significantly lower minimal glucose values and detected more hyperglycemic events compared to intermittent blood glucose values in eight patients, in whom the device displayed accurate results with a MARD &lt; 14 % (Table <ref type="table">4b</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Reliability, feasibility and nurse acceptance</head><p><s>This prospective study was initially conducted with the intention of implementing a minimally invasive, simple to use CGM device in our ICU, in order to improve glycemic control.</s><s>Unfortunately, application and performance were not as reliable as expected.</s><s>Numerous sensors were removed prematurely, and the percentage of data gaps in relation to the expected sensor running time exceeded the time specified within the consensus recommendations of ICU experts <ref type="bibr" target="#b19">[20]</ref>.</s><s>The fact that we did not demand additional calibrations from the nursing staff and that they were not involved in troubleshooting may have contributed to the extent of data gaps and the poor performance.</s><s>Since 7.4 % of data gaps were not device related, the data display during 85.6 % of the sensor running time after initialization could be corrected to 93 %.</s><s>The high rate of accidentally removed sensors underlines the vulnerable use of the subcutaneous device in intensive care.</s><s>This is supported by the opinion of our ICU nursing staff.</s><s>More experience with a device may enhance feasibility.</s><s>However, device-related issues, which are not improvable by experience, occurred frequently.</s></p><p><s>Recently published investigations evaluating the same device reported minimal differences in reliability, but the clinically relevant results were concordant <ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b18">[19]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Point accuracy and confounding factors</head><p><s>The subcutaneous device did not fulfill the suggested accuracy criteria for CGM in critically ill patients, specified within the consensus recommendations of ICU experts <ref type="bibr" target="#b19">[20]</ref>.</s><s>The distribution in the Clarke error grid <ref type="bibr" target="#b22">[23]</ref> was unsatisfactory, as all 532 comparative readings of this analysis should have been located in zone A or B, preferably in zone A. The Surveillance Error-Grid <ref type="bibr" target="#b23">[24]</ref>, which promises to be closer to clinical routine, showed similar degrees of risk.</s><s>In the Bland-Altman plot, the mean bias indicated that there was no systematic error <ref type="bibr" target="#b21">[22]</ref>.</s><s>However, 95 % of the values were within 128 mg/dl of the reference glucose.</s><s>These wide limits of agreement illustrated a high random error <ref type="bibr" target="#b21">[22]</ref>.</s><s>The detection of dysglycemia was critical.</s><s>The results considering MARD values within the 12.5 % range, and Clarke error grid and Bland-Altman plot are precisely consistent with those reported by Van Hooijdonk et al. <ref type="bibr" target="#b16">[17]</ref>.</s><s>Two further studies showed slightly better accuracy of the same system <ref type="bibr" target="#b17">[18,</ref><ref type="bibr" target="#b18">19]</ref>.</s><s>Although specifically designed for ICU use, the investigated subcutaneous device failed to achieve comparatively accurate results in all recently published trials <ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b18">[19]</ref>, as opposed to the CGM technologies quantifying glucose concentration in the vascular compartment of critically ill patients <ref type="bibr" target="#b24">[25]</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref><ref type="bibr" target="#b27">[28]</ref>.</s><s>This leads to the conclusion that, with the intention to administrate insulin therapy, the subcutaneous glucose determination is not the proper method to estimate blood glucose levels during the acute phase of severe illness.</s></p><p><s>Inaccuracies may be attributed to a physiological time delay relating to the glucose diffusion from the plasma to the interstitial compartment <ref type="bibr" target="#b28">[29,</ref><ref type="bibr" target="#b29">30]</ref>.</s><s>In healthy humans and diabetes patients, this time delay has been observed to range from 0 to 40 min in various studies summarized by Scuffi et al. <ref type="bibr" target="#b29">[30]</ref>.</s><s>Rebrin et al. found no evidence that physiological delays exceeded 5-10 min and argued that device-related processes are responsible for longer periods <ref type="bibr" target="#b30">[31]</ref>.</s><s>Moreover, Boyne et al. addressed the issue of random inter-sensor time discrepancies, which were quantitatively similar to physiological time delays, when comparing measurements of two subcutaneous sensors in the same individual <ref type="bibr" target="#b31">[32]</ref>.</s><s>Factors influencing the glucose diffusion rate, such as blood flow, peripheral microcirculation, and metabolic rate of subcutaneous tissue and adjacent cells, are all frequently altered in critically ill patients <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b32">33]</ref>.</s><s>We found no indication for a fixed time shift, but time delay and interstitial sensor accuracy may vary depending on the patient's condition.</s><s>There is evidence to support this hypothesis, since the use of vasopressors and a higher SOFA Score downgraded sensor accuracy in the present trial.</s><s>In contrast, the accuracy of a subcutaneous CGM device was significantly improved in patients with septic shock compared to patients without sepsis <ref type="bibr" target="#b33">[34]</ref>.</s><s>Further studies cited that circulatory shock requiring norepinephrine therapy and impaired microcirculation had no influence on subcutaneous sensor accuracy <ref type="bibr" target="#b34">[35,</ref><ref type="bibr" target="#b35">36]</ref>.</s><s>Variable subcutaneous oxygen concentration may interfere with the glucose oxidase.</s><s>We did not investigate tissue paO2, but arterial paO2, as a correlating factor, had no clinically relevant impact on accuracy.</s></p><p><s>Glucose homeostasis is affected by the peripheral glucose uptake <ref type="bibr" target="#b32">[33]</ref>.</s><s>Inflammation may lead to an insufficient GLUT 4 translocation to sarcolemmal membrane <ref type="bibr" target="#b2">[3]</ref>.</s><s>This mechanism resulted in an impaired glucose supply in skeletal muscle cells in ICU patients <ref type="bibr" target="#b2">[3]</ref>.</s><s>A decreased glucose uptake was observed in adipocytes of septic rats <ref type="bibr" target="#b36">[37]</ref>.</s><s>We hypothesize that an insufficient GLUT 4 translocation may occur in subcutaneous tissue cells of critically ill patients.</s><s>This may influence the accuracy of a (See figure on previous page.)</s><s>Fig. <ref type="bibr" target="#b2">3</ref> Bland-Altman plot, Clarke error grid, Color-coded Surveillance Error-Grid.</s><s>n = 532 comparative samples.</s><s>a Bland-Altman plot.</s><s>The mean bias indicates whether there is a systematic error.</s><s>Upper and lower limits were calculated by mean bias ±1.96 × standard deviation of the difference between BG and sensor glucose and represent random variations around the mean bias.</s><s>If there is a Gaussian distribution, 95 % of points are located between these limits.</s><s><ref type="bibr" target="#b21">[22,</ref><ref type="bibr" target="#b40">41]</ref>.</s><s>b Clarke error grid.</s><s>Distribution: A = 76.9 %, B = 21.6 %, C = 0.2 %, D = 0.9 %, E = 0.4 %.</s><s>Zones A (CGM data ≤20 % deviation from BG) and B are considered as clinically acceptable zones, whereas values in zones C, D and E are increasingly dangerous for the patient, and zone E may lead to adverse therapeutic decisions.</s><s><ref type="bibr" target="#b22">[23]</ref>.</s><s>c Color-coded Surveillance Error-Grid.</s><s>The Surveillance Error-Grid software is available at http://www.diabetestechnology.org/SEGsoftware/Surveillance-Error-Grid-Analysis.xlsm.</s><s>Last Accessed: Dec 11 2015 <ref type="bibr" target="#b23">[24]</ref> Fig. <ref type="figure">4</ref> Confounding factors on MARD. a (left): Association between MARD and individual daily blood glucose variability shown in first and second standard deviation of reference glucose.</s><s>First boxplot The CGM device shows acceptable accuracy* (MARD median 10.9 %) if the blood glucose variability is low (first standard deviation).</s><s>Second boxplot Accuracy deteriorates (MARD median 24 %) during increased blood glucose variability (second standard deviation).</s><s>b (right): Association between MARD and blood glucose ranges.</s><s>Second boxplot The CGM device shows acceptable accuracy* (MARD median 8.8 %) in blood glucose ranges between 80 and 179 mg/dl.</s><s>First and Third boxplots Accuracy deteriorates in the hypoglycemic range (MARD median 65.8 %) and during severe hyperglycemia (MARD median 16 %).</s><s>*According to criteria specified within the consensus recommendations <ref type="bibr" target="#b19">[20]</ref>, MARD should be &lt;14 % subcutaneous CGM device, when compared to blood glucose.</s><s>Consequently, it can still be assumed that subcutaneous CGM reflects actual insulin-dependent tissue glucose dynamics, which may be clinically relevant <ref type="bibr" target="#b31">[32]</ref>.</s></p><p><s>We identified that the sensor accuracy deteriorated in patients with elevated glycemic variability, as well as in the hyperglycemic range.</s><s>Unfortunately, inaccuracies of CGM occurred particularly often when the need for CGM would have been most beneficial.</s><s>Delayed diffusion processes become increasingly significant during rapid glucose oscillations <ref type="bibr" target="#b29">[30,</ref><ref type="bibr" target="#b32">33]</ref> and may contribute to the adverse influence of glucose variability and hyperglycemia on sensor performance.</s><s>In healthy volunteers, the interstitial glucose was similar to venous glucose during steady-state conditions, but an increased time delay was observed when glucose levels were rapidly elevated by glucose infusion <ref type="bibr" target="#b37">[38]</ref>.</s><s>We could not confirm the findings reported by van Hooijdonk et al. that accuracy was influenced by a history of diabetes <ref type="bibr" target="#b16">[17]</ref>.</s><s>As already assumed in this study, inaccuracies in critically ill diabetic patients were possibly attributable to glucose fluctuations <ref type="bibr" target="#b16">[17]</ref>.</s><s>Although intravascular and interstitial space should be</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Table 4 Potential benefits of CGM in our ICU</head><p><s>Intra-individual longitudinal and parallel analysis, target range 71-149 mg/dl Results are expressed as median with interquartile range or as absolute numbers with percentages Glycemic lability index: time interval 1440 min = 24 h, glucose in mg/dl, sampling interval: blood glucose 120 min = 2 h, sensor glucose 1 min Number of hypoglycemia or hyperglycemia: only events of newly developed hypoglycemia or hyperglycemia were considered in the analysis BGA blood glucose analysis, SD standard deviation, GLI glycemic lability index § Wilcoxon test before and during p = .123;</s><s>before and after p = .05,</s><s>during and after p = .005</s><s># Wilcoxon test before and during p = .241,</s><s>before and after p = .415,</s><s>during and after p = .013</s><s>* BGAs during CGM data gaps and times of temporary system failure are included considered as different glucose compartments, the sensor technology requires blood glucose calibrations <ref type="bibr" target="#b32">[33,</ref><ref type="bibr" target="#b38">39]</ref>.</s><s>This is a major concern, since sensor calibration during glucose alterations may subsequently cause and amplify inaccuracies <ref type="bibr" target="#b32">[33]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Safety statement</head><p><s>The local complication rate was acceptable, but critical safety issues arose as a consequence of inaccurate measurements.</s><s>Clarke error grid and Surveillance Error-Grid showed potentially dangerous situations for the patients.</s><s>Clinicians need to be aware of the fact that this device is not safe to guide insulin therapy.</s><s>Even if used only to support common glucose control, this device can lead to confusing situations in the ICU routine of glucose management.</s><s>As our experience showed, clinicians should always critically question the displayed CGM data.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Potential benefits of CGM in our ICU</head><p><s>Glucose monitoring with the CGM system did not improve glycemic control in the longitudinal, intraindividual analysis.</s><s>Low accuracy, as well as low nurse acceptance, may be potential reasons.</s><s>Besides, the time in target of our severely ill patients with and without CGM was high.</s><s>As a consequence, it may be difficult to demonstrate improved control even with a device that had reasonable accuracy.</s><s>Conversely, if CGM was accurate, it showed potential benefits.</s><s>In contrast to the findings of Brunner et al., glycemic variability was not significantly different when calculated from accurate continuous values as compared to less frequent blood glucose values <ref type="bibr" target="#b39">[40]</ref>.</s><s>If accurate CGM systems and adapted insulin protocols are implemented in the ICU, further research is required to evaluate long-term effects on clinical outcomes in RCTs.</s><s>Insulin therapy guided by CGM did not impact on time in target range and glycemic variability in previous RCTs <ref type="bibr" target="#b12">[13,</ref><ref type="bibr" target="#b13">14,</ref><ref type="bibr" target="#b39">40]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Potential areas for improvements</head><p><s>• Calibration should only be performed during "steadystate" glucose levels, and not during rapid glucose fluctuations <ref type="bibr" target="#b32">[33,</ref><ref type="bibr" target="#b38">39]</ref> or adapted within a special calibration algorithm • Improved fixation method or different localization to avoid accidental sensor removal • Wireless device to avoid data gaps caused by occasional disconnection during bedding or mobilization, as well as accidental removals • Integration of the continuous glucose display into the established patient monitor to reduce additional equipment • Inclusion of a suggestion according to the local insulin treatment protocol into monitor</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Limitations</head><p><s>Firstly, this was a point accuracy analysis, in which only the concurrent blood glucose sample was considered.</s><s>The reporting of glucose trending is not possible in this trial.</s><s>Secondly, in the clinical setting we cannot exclude that there is a delay between the taking of a blood sample and the actual analysis via blood gas analyzer, where the time-point is documented <ref type="bibr" target="#b11">[12,</ref><ref type="bibr" target="#b19">20]</ref>.</s><s>Thirdly, not all nurses were familiar with the device after the initial instructions provided by the manufacturer.</s><s>Fourthly, the low response rate to the questionnaires may bias the results of the nurse acceptance survey.</s><s>Fifthly, due to the low number of actual hypoglycemic events, there is a lack of evidence to draw a conclusion concerning the accuracy during hypoglycemia.</s><s>It has to be stressed that this study was not designed to evaluate potential benefits of CGM on glucose control and there was no variation to the insulin protocol.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusion</head><p><s>The Medtronic System did not perform with satisfactory accuracy, feasibility or nursing acceptance when evaluated in 20 medical-surgical ICU patients.</s><s>Low point accuracy and prolonged data gaps significantly limited the potential clinical usefulness of the CGM trend data.</s><s>Future studies are required to determine the clinical value of the real-time Sentrino ® glucose trend data and alarms, using a validated nurse-driven insulin dosing algorithm in order to improve the safety and efficacy of blood glucose control in hospitalized patients.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 2</head><label>2</label><figDesc><div><p><s>Fig. 2 Analysis criteria.</s><s>Detailed criteria for the evaluation of subcutaneous CGM in the ICU</s></p></div></figDesc><graphic coords="4,62.88,95.08,470.52,312.00" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="9,106.85,408.21,382.32,240.36" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1</head><label>1</label><figDesc><div><p><s>Patient characterization n = 20 patientsResults are expressed as median with interquartile range or as absolute numbers with percentages of n = 20 patients BMI body mass index, ARDS acute respiratory distress syndrome, ECMO extracorporeal membrane oxygenation, ECLA extracorporeal lung assist, SIRS systemic inflammatory response syndrome, SOFA sequential organ failure assessment, APACHE acute physiology and chronic health evaluation, ICU intensive care unit, CGM continuous glucose monitoring</s></p></div></figDesc><table><row><cell>Age</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2 Mean glucose level, glycemic variability and glycemic events</head><label>2</label><figDesc></figDesc><table><row><cell>Number of comparative glucose readings</cell><cell>532</cell><cell>532</cell><cell></cell></row><row><cell>Readings per patient</cell><cell>28 [18/34]</cell><cell>28 [18/34]</cell><cell></cell></row><row><cell>Mean glucose level per patient (mg/dl)</cell><cell>133.8 [128.4/147.5]</cell><cell cols="2">133.7 [124.3/150.1]*</cell></row><row><cell>Glucose variability per patient measured in</cell><cell>24.8 [19.9/35.2]</cell><cell cols="2">32.5 [25.2/42.2]  §</cell></row><row><cell>SD (mg/dl)</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">Glycemic events: number and percentage of n = 19 patients Severe hypoglycemia (≤40 mg/dl) 1 (5.3 %)</cell><cell>1 (5.3 %)</cell><cell></cell></row><row><cell>Moderate hypoglycemia (41-70 mg/dl)</cell><cell>1 (5.3 %)</cell><cell>10 (52.6 %)</cell><cell></cell></row><row><cell>Euglycemia (71-149 mg/dl)</cell><cell>19 (100 %)</cell><cell>19 (100 %)</cell><cell></cell></row><row><cell>Moderate hyperglycemia (150-179 mg/dl)</cell><cell>18 (94.7 %)</cell><cell>19 (100 %)</cell><cell></cell></row><row><cell>Severe hyperglycemia (&gt;179 mg/dl)</cell><cell>15 (78.9 %)</cell><cell>11 (57.9 %)</cell><cell></cell></row><row><cell>Glycemic events: number and percentage of</cell><cell>158 (29.7 %)</cell><cell>188 (35.3 %)</cell><cell></cell></row><row><cell>n = 532 readings Severe hypoglycemia (≤40 mg/dl)</cell><cell>1 (0.2 %)</cell><cell>1 (0.2 %)</cell><cell>Chi-square test: p &lt; 0.001 for crosstabulation see</cell></row><row><cell>Moderate hypoglycemia (41-70 mg/dl)</cell><cell>2 (0.4 %)</cell><cell>15 (2.8 %)</cell><cell>supplement</cell></row><row><cell>Euglycemia (71-149 mg/dl)</cell><cell>374 (70.3 %)</cell><cell>344 (64.7 %)</cell><cell></cell></row><row><cell>Moderate hyperglycemia (150-179 mg/dl)</cell><cell>96 (18.0 %)</cell><cell>101 (19 %)</cell><cell></cell></row><row><cell>Severe hyperglycemia (&gt;179 mg/dl)</cell><cell>59 (11.1 %)</cell><cell>71 (13.3 %)</cell><cell></cell></row></table><note><p><s>n = 19 patients Results are expressed as median with interquartile range or as absolute numbers with percentages SD standard deviation * p = 1.0; § p = 0.002 Reference blood glucose Comparative CGM reading</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 3 Reliability and feasibility</head><label>3</label><figDesc></figDesc><table><row><cell>n = 20 patients, 31 sensors Results are expressed as median with interquartile range or as absolute numbers with percentages</cell></row><row><cell>MRI magnetic resonance imaging</cell></row></table></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head><p><s>Preliminary data of this manuscript were presented at ESICM Lives 2015 as an e-poster <ref type="bibr" target="#b41">[42]</ref>.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Abbreviations</head><p><s>ICU: intensive care unit; BG: blood glucose; CGM: continuous glucose monitoring; CI: confidence interval; ICU: intensive care unit; MARD: mean absolute relative difference; PDMS: patient data management system; RCT: randomized controlled trial; SOFA: sequential organ failure assessment.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Authors' contributions</head><p><s>TW and LE contributed equally to this work, designed the study, performed data acquisition, analyzed and interpreted data and wrote the manuscript.</s><s>JP performed data acquisition, analyzed nurse acceptance and critically revised the manuscript for important intellectual content.</s><s>RM critical revised the manuscript and gave input on calculation of glycemic variability.</s><s>SK, CS, MH critically revised the manuscript for important intellectual content.</s><s>SWC revised the manuscript, performed statistical analysis and made substantial contributions to data interpretation.</s><s>All authors read and approved the final manuscript.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Additional file</head><p><s>Additional file 1: Supplementary Method.</s><s>CGM Device.</s><s>Supplementary Tables.</s><s>Table <ref type="table">S1</ref>.</s><s>The local insulin protocol.</s><s>Table <ref type="table">S2</ref>.</s><s>Detection of dysglycemic events.</s><s>Table <ref type="table">S3a</ref>.</s><s>Confounding factors on MARD.</s><s>Table <ref type="table">S3b</ref>.</s><s>Spearman´s correlation of paO2, temperature, lactate, pH-value, hemoglobin, potassium and SOFA-Score and MARD.</s><s>Supplementary Figures.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Competing interests</head><p><s>The authors declare that they have no competing interests.</s><s>Medtronic Sentrino ® provided two CGM systems for the duration of the study, but had no influence on study design and data analysis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Availability of data and materials</head><p><s>Ethical restrictions prevent public sharing of data.</s><s>Editors, reviewers and interested researchers should contact the corresponding author or dairesearchdata@charite.de to request data access.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Consent for publication</head><p><s>Informed consent included consent for publication.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Ethics approval and consent to participate</head><p><s>The local ethics committee, Charité-Universitätsmedizin Berlin Ethikkommission, approved the study (Charité-EA2/095/14). Informed consent was given by the patient or legal proxy.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Funding</head><p><s>This investigation was a preliminary study within the European Critical Care Research Network (ECCRN) Grant for Practice Improvement in ICU Nutrition 2013 given to TW. SWC received financial support from Deutsche Forschungsgemeinschaft (DFG) KFO 192 TP3.</s><s>Medtronic provided two CGM monitor systems for the duration of the study, but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Stress-induced hyperglycemia</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Mccowen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Malhotra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">R</forename><surname>Bistrian</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care Clin</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="107" to="124" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Metabolic response to the stress of critical illness</title>
		<author>
			<persName><forename type="first">J-C</forename><surname>Preiser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Ichai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J-C</forename><surname>Orban</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Abj</forename><surname>Groeneveld</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Anaesth</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="page" from="945" to="954" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Critical illness myopathy and GLUT4: significance of insulin and muscle contraction</title>
		<author>
			<persName><forename type="first">S</forename><surname>Weber-Carstens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Schneider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Wollersheim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Assmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bierbrauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Marg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Respir Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">187</biblScope>
			<biblScope unit="page" from="387" to="396" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Krinsley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mayo Clin Proc</title>
		<imprint>
			<biblScope unit="volume">78</biblScope>
			<biblScope unit="page" from="1471" to="1478" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Glycemic variability: a strong independent predictor of mortality in critically ill patients*</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Krinsley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="3008" to="3013" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Hypoglycemia and risk of death in critically ill patients</title>
		<author>
			<persName><surname>Nice-Sugar Study Investigators</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Finfer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Chittock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Norton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Myburgh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">367</biblScope>
			<biblScope unit="page" from="1108" to="1118" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Intensive insulin therapy in critically ill patients</title>
		<author>
			<persName><forename type="first">G</forename><surname>Van Den Berghe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Wouters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Weekers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Verwaest</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bruyninckx</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schetz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">345</biblScope>
			<biblScope unit="page" from="1359" to="1367" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Intensive insulin therapy in the medical ICU</title>
		<author>
			<persName><forename type="first">G</forename><surname>Van Den Berghe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Wilmer</forename><forename type="middle">A</forename><surname>Hermans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Meersseman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Wouters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Milants</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">354</biblScope>
			<biblScope unit="page" from="449" to="461" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Intensive versus conventional glucose control in critically ill patients</title>
		<author>
			<persName><surname>Nice-Sugar Study Investigators</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Finfer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Chittock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Sy-S</forename><surname>Su</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Blair</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Foster</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">360</biblScope>
			<biblScope unit="page" from="1283" to="1297" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Toward understanding tight glycemic control in the ICU: a systematic review and metaanalysis</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Marik</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chest J</title>
		<imprint>
			<biblScope unit="volume">137</biblScope>
			<biblScope unit="page">544</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<author>
			<persName><forename type="first">J</forename><surname>Wernerman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Desaive</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Finfer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Foubert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Furnary</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Holzinger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Continuous glucose control in the ICU: report of a 2013 round table meeting</title>
				<imprint>
			<date type="published" when="2014">2014</date>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page">226</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Evaluation of nursing work effort and perceptions about blood glucose testing in tight glycemic control</title>
		<author>
			<persName><forename type="first">D</forename><surname>Aragon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Crit Care</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="370" to="377" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Insulin treatment guided by subcutaneous continuous glucose monitoring compared to frequent point-of-care measurement in critically ill patients: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">T</forename><surname>Boom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Sechterberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rijkenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kreder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Bosman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Wester</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care</title>
		<imprint>
			<date type="published" when="2014">2014. 2015</date>
		</imprint>
	</monogr>
	<note>cited</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Real-time continuous glucose monitoring in critically ill patients</title>
		<author>
			<persName><forename type="first">U</forename><surname>Holzinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Warszawska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kitzberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wewalka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Miehsler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Herkner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="467" to="472" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Accuracy and reliability of a subcutaneous continuous glucose-monitoring system in critically ill patients*</title>
		<author>
			<persName><forename type="first">R</forename><surname>Brunner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kitzberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Miehsler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Herkner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Madl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Holzinger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="659" to="664" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Accuracy of intra-arterial and subcutaneous continuous glucose monitoring in postoperative cardiac surgery patients in the ICU</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Sechterberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phj</forename><surname>Van Der Voort</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Strasma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Devries</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Diabetes Sci Technol</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="663" to="667" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Point accuracy and reliability of an interstitial continuous glucose-monitoring device in critically ill patients: a prospective study</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Van Hooijdonk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Leopold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Winters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Binnekade</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">P</forename><surname>Juffermans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Horn</surname></persName>
		</author>
		<ptr target="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382831/" />
	</analytic>
	<monogr>
		<title level="j">Crit Care</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<date type="published" when="2015-09-12">2015. 2015 Sep 12</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Performance of the medtronic sentrino continuous glucose management (CGM) system in the cardiac intensive care unit</title>
		<author>
			<persName><forename type="first">M</forename><surname>Kosiborod</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Gottlieb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Sekella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Peterman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Grodzinsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Kennedy</surname></persName>
		</author>
		<ptr target="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4212554/" />
	</analytic>
	<monogr>
		<title level="j">BMJ Open Diabetes Res Care</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<date type="published" when="2014">2014. 2015 Sep 12</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Continuous glucose monitoring on the ICU using a subcutaneous sensor</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Punke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Decker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Wodack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Reuter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kluge</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Med Klin Intensivmed Notfallmedizin</title>
		<imprint>
			<biblScope unit="volume">110</biblScope>
			<biblScope unit="page" from="360" to="363" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Clinical review: consensus recommendations on measurement of blood glucose and reporting glycemic control in critically ill adults</title>
		<author>
			<persName><forename type="first">S</forename><surname>Finfer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wernerman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J-C</forename><surname>Preiser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Cass</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Desaive</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hovorka</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page">229</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">R</forename><surname>Hill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">S</forename><surname>Oliver</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Choudhary</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Levy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Hindmarsh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Matthews</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes Technol Ther</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="921" to="928" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Comparing methods of measurement: why plotting difference against standard method is misleading</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Bland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Altman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">346</biblScope>
			<biblScope unit="page" from="1085" to="1087" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Evaluating clinical accuracy of systems for self-monitoring of blood glucose</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">L</forename><surname>Clarke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Cox</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Gonder-Frederick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Carter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Pohl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="622" to="628" />
			<date type="published" when="1987">1987</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">The surveillance error grid</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Klonoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lias</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Vigersky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Clarke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Parkes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Sacks</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Diabetes Sci Technol</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="658" to="672" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Evaluation of a continuous blood glucose monitoring system using central venous microdialysis</title>
		<author>
			<persName><forename type="first">F</forename><surname>Schierenbeck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Franco-Cereceda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Liska</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Diabetes Sci Technol</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="1365" to="1371" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Accuracy and limitations of continuous glucose monitoring using spectroscopy in critically ill patients</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Van Hooijdonk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Winters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Fischer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Van Dongen-Lases</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Krinsley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J-C</forename><surname>Preiser</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Intensive Care</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">8</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">The development of a continuous intravascular glucose monitoring sensor</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">C</forename><surname>Crane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">P</forename><surname>Barwell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Gopal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gopichand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Higgs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">D</forename><surname>James</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Diabetes Sci Technol</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="751" to="761" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Continuous intra-arterial blood glucose monitoring using quenched fluorescence sensing in intensive care patients after cardiac surgery: phase II of a product development study</title>
		<author>
			<persName><forename type="first">L</forename><surname>Macken</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">J</forename><surname>Flower</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bird</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Hammond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Yarad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bass</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care Resusc J Australas Acad Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="190" to="196" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Time lag of glucose from intravascular to interstitial compartment in humans</title>
		<author>
			<persName><forename type="first">A</forename><surname>Basu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Dube</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Slama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Errazuriz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Amezcua</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">C</forename><surname>Kudva</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page" from="4083" to="4087" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Minimizing the impact of time lag variability on accuracy evaluation of continuous glucose monitoring systems</title>
		<author>
			<persName><forename type="first">C</forename><surname>Scuffi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Lucarelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Valgimigli</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Diabetes Sci Technol</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="1383" to="1391" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Use of subcutaneous interstitial fluid glucose to estimate blood glucose: revisiting delay and sensor offset</title>
		<author>
			<persName><forename type="first">K</forename><surname>Rebrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">F</forename><surname>Sheppard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Steil</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Diabetes Sci Technol</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="1087" to="1098" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Timing of changes in interstitial and venous blood glucose measured with a continuous subcutaneous glucose sensor</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Boyne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Silver</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kaplan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Saudek</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="2790" to="2794" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">A tale of two compartments: interstitial versus blood glucose monitoring</title>
		<author>
			<persName><forename type="first">E</forename><surname>Cengiz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">V</forename><surname>Tamborlane</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes Technol Ther</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="11" to="16" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Real-time continuous glucose monitoring in an intensive care unit: better accuracy in patients with septic shock</title>
		<author>
			<persName><forename type="first">C</forename><surname>Lorencio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Leal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bonet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bondia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Palerm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tache</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes Technol Ther</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="568" to="575" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Impact of shock requiring norepinephrine on the accuracy and reliability of subcutaneous continuous glucose monitoring</title>
		<author>
			<persName><forename type="first">U</forename><surname>Holzinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Warszawska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kitzberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Herkner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Pgh</forename><surname>Metnitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Madl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Intensive Care Med</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="1383" to="1389" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Microcirculation and its relation to continuous subcutaneous glucose sensor accuracy in cardiac surgery patients in the intensive care unit</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Siegelaar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Barwari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hermanides</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phj</forename><surname>Van Der Voort</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jbl</forename><surname>Hoekstra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Devries</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Thorac Cardiovasc Surg</title>
		<imprint>
			<biblScope unit="volume">146</biblScope>
			<biblScope unit="page" from="1283" to="1289" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Sepsis inhibits insulin-stimulated glucose transport in isolated rat adipocytes</title>
		<author>
			<persName><forename type="first">M</forename><surname>Igarashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yamatani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Fukase</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Daimon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ohnuma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Takahashi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes Res Clin Pract</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="213" to="218" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Characterization by microdialysis of intracellular glucose level in subcutaneous tissue in humans</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Jansson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Fowelin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Lonnroth</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">255</biblScope>
			<biblScope unit="page" from="E218" to="220" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Can interstitial glucose assessment replace blood glucose measurements?</title>
		<author>
			<persName><forename type="first">K</forename><surname>Rebrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Steil</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes Technol Ther</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="461" to="472" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Glycemic variability and glucose complexity in critically ill patients: a retrospective analysis of continuous glucose monitoring data</title>
		<author>
			<persName><forename type="first">R</forename><surname>Brunner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Adelsmayr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Herkner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Madl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Holzinger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page">R175</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Statistical methods for assessing agreement between two methods of clinical measurement</title>
		<author>
			<persName><forename type="first">Martin</forename><surname>Bland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Altman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">327</biblScope>
			<biblScope unit="page" from="307" to="310" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Accuracy of a subcutaneous continuous glucose management system in critically ill patients</title>
		<author>
			<persName><forename type="first">L</forename><surname>Engelhardt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Wollersheim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Pachulla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Mörgeli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Balzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Mai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Weber-Carstens</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Intensive Care Med Exp</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">A291</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
